This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Norgine Bv. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Mohd Zainuddin: Innovator in CCR9 Modulation
Introduction
Mohd Zainuddin is a notable inventor based in Kanpur, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the CCR9 receptor. His work has implications for treating various inflammatory and immune disorders.
Latest Patents
Zainuddin holds a patent for "Compounds useful as CCR9 modulators." This invention relates to compounds that can modulate the function of the CCR9 receptor by acting as partial agonists, antagonists, or inverse agonists. These compounds may be beneficial in treating, preventing, or ameliorating diseases associated with CCR9 activation, including inflammatory bowel diseases (IBD).
Career Highlights
Mohd Zainuddin is currently associated with Norgine Bv, where he continues to innovate in the field of pharmaceutical compounds. His expertise in CCR9 modulation positions him as a key player in the development of new therapeutic strategies.
Collaborations
Zainuddin has collaborated with notable colleagues such as Rajagopal Bakthavatchalam and Manas Kumar Basu, contributing to a dynamic research environment focused on advancing medical science.
Conclusion
Mohd Zainuddin's work in CCR9 modulation represents a significant advancement in the treatment of inflammatory diseases. His innovative approach and collaboration with other experts highlight the importance of teamwork in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile